NCT01118351 2019-05-01Sunitinib Malate in Treating Patients With Recurrent Transitional Cell Bladder CancerCase Comprehensive Cancer CenterPhase 2 Terminated19 enrolled 11 charts
NCT00900302 2016-02-10OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerOHSU Knight Cancer InstituteCompleted98 enrolled
NCT00553124 2014-01-10Different Factors Affecting Patients With Newly Diagnosed Bladder CancerNational Cancer Institute (NCI)Phase 3 Unknown3,400 enrolled
NCT01118039 2013-08-07Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract CancerNational Cancer Institute (NCI)Phase 2 Unknown41 enrolled